Imperial College London
Portrait Picture

Peter Openshaw - Professor of Experimental Medicine

Faculty of Medicine, National Heart & Lung Institute

Proconsul, Professor of Experimental Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 3854p.openshaw Website CV

 
 
//

Assistant

 

Ms Gale Lewis +44 (0)20 7594 0944

 
//

Location

 

353Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Barnes:2023:immadv/ltad024,
author = {Barnes, MVC and Mandla, A and Smith, E and Maskuniitty, M and Openshaw, PJM and HIC-Vac, meeting contributors},
doi = {immadv/ltad024},
journal = {Immunotherapy Advances},
title = {Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022},
url = {http://dx.doi.org/10.1093/immadv/ltad024},
volume = {3},
year = {2023}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - HIC-Vac is an international network of researchers dedicated to developing human infection challenge studies to accelerate vaccine development against pathogens of high global impact. The HIC-Vac Annual Meeting (3rd and 4th November 2022) brought together stakeholders including researchers, ethicists, volunteers, policymakers, industry partners, and funders with a strong representation from low- and middle-income countries. The network enables sharing of research findings, especially in endemic regions. Discussions included pandemic preparedness and the role of human challenge to accelerate vaccine development during outbreak, with industry speakers emphasising the great utility of human challenge in vaccine development. Public consent, engagement, and participation in human challenge studies were addressed, along with the role of embedded social science and empirical studies to uncover social, ethical, and regulatory issues around human infection challenge studies. Study volunteers shared their experiences and motivations for participating in studies. This report summarises completed and ongoing human challenge studies across a variety of pathogens and demographics, and addresses other key issues discussed at the meeting.
AU  - Barnes,MVC
AU  - Mandla,A
AU  - Smith,E
AU  - Maskuniitty,M
AU  - Openshaw,PJM
AU  - HIC-Vac,meeting contributors
DO  - immadv/ltad024
PY  - 2023///
SN  - 2732-4303
TI  - Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022
T2  - Immunotherapy Advances
UR  - http://dx.doi.org/10.1093/immadv/ltad024
UR  - https://www.ncbi.nlm.nih.gov/pubmed/38020312
UR  - https://doi.org/10.1093/immadv/ltad024
UR  - http://hdl.handle.net/10044/1/108653
VL  - 3
ER  -
Download